DNA-PK enforces the S/G2 checkpoint in ATM-deficient cells to limit ATR inhibitor efficacy
Timothy B. Branigan, Roshen Alharthi, Bose S. Kochupurakkal, Jie Hao, Steffie Revia, Joachim Albers, Mu-Yan Cai, Yuqing Jiao, Kelsey McQueen, Sirisha Mukkavalli, Ian A. Roundtree, Gregory Michael Cote, Prafulla C. Gokhale, Kalindi Parmar, Alan D. D’Andrea, , Geoffrey Ira Shapiro
This study shows DNA-PK enforces the S/G2 checkpoint in ATM-deficient cells, reducing ATR inhibitor efficacy, and suggests combining ATR and DNA-PK inhibition could enhance treatment in such cancers.
bioRxiv · Oct 28, 2026 · PreprintCancer Biology